Navigation and service

Publications in 2002

Authors from the Paul-Ehrlich-Institut are highlighted in bold face type. Where online abstracts or full texts are available of the publications, there is a link to these texts.

Andersson AC, Venables PJW, Tönjes RR, Scherer J, Eriksson L, Larsson E (2002): Developmental expression of HERV-R (ERV3) and HERV-K in human tissue.
Virology 297: 220-225.
Online-Abstract

Ayuso R, Lehrer SB, Reese G (2002): Identification of continuous, allergenic regions of the major shrimp allergen Pen a 1 (tropomyosin).
Int Arch Allergy Immunol 127: 27-37.

Ayuso R, Reese G, Leong-Kee S, Plante M, Lehrer SB (2002): Molecular basis of arthropod cross-reactivity: IgE-binding cross-reactive epitopes of shrimp, house dust mite and cockroach tropomyosins.
Int Arch Allergy Immunol 129: 38-48.

Ballmer-Weber BK, Hoffmann A, Wüthrich B, Lüttkopf D, Pompei C, Wangorsch A, Kästner M, Vieths S (2002): Influence of food processing on the allergenicity of celery: DBPCFC with celery spice and cooked celery in patients with celery allergy.
Allergy 57: 228-235.
Online-Abstract

Ballmer-Weber BK, Scheurer S, Fritsche P, Enrique E, Cistero-Bahima A, Haase T, Wüthrich B (2002): Component-resolved diagnosis with recombinant allergens in patients with cherry allergy.
J Allergy Clin Immunol 110: 167-173.
Online-Abstract

Barchet W, Cella M, Odermatt B, Asselin-Paturel C, Colonna M, Kalinke U (2002): Virus-induced interferon production by a dendritic cell subset in the absence of feedback signaling in vivo.
J Exp Med 195: 507-516.
Online-Abstract

Bieda K, Pani MA, van der Auwera B, Seidl C, Tönjes RR, Gorus F, Usadel KH, Badenhoop K (2002): A retroviral long terminal repeat adjacent to the HLA DQB1 gene (DQ-LTR13) modifies type I diabetes susceptibility on high risk DQ haplotypes.
Diabetologia 45: 443-447.
Online-Abstract

Binninger-Schinzel D, Norley S, Adler S, Oberg HH, Kurth R (2002): Simian Immunodeficiency Viruses with Defective Nef Genes Show Increased Susceptibility to the Noncytotoxic Antiviral Activity of CD8+ Lymphocytes.
Virology 294: 209-221.
Online-Abstract

Blümel J, Schmidt I, Effenberger W, Seitz H, Willkommen H, Brackmann HH, Löwer J, Eis-Hübinger AM (2002): Parvovirus B19 transmission by heat-treated clotting factor concentrates.
Transfusion 42: 1473-1481.
Online-Abstract

Blümel J, Schmidt I, Willkommen H, Löwer J (2002): Inactivation of parvovirus B19 during pasteurization of human serum albumin.
Transfusion 42: 1011-1018.
Online-Abstract

Bobkova M, Stitz J, Engelstädter M, Cichutek K, Buchholz CJ (2002): Identification of R-peptides in envelope proteins of C-type retroviruses.
J Gen Virol 83: 2241-2246.
Online-Abstract

Bornhak H, Dörr V, Halbauer J, Meyer-Lüerßen D, Odenthal J, Siekmeier R, Will HG (2002): Die Anforderungen der Medizinprodukte-Sicherheitsplan-Verordnung für In-vitro-Diagnostika im Rahmen des Medizinproduktegesetzes.
Medizin Produkte Recht 2: 1-14.
Volltext

Brown F, Seitz R: Advances in Transfusion Safety - 2001.
In: Brown F, Seitz R (Hrsg.), Basel: Karger, 2002. 145 S. ISBN 3-8055-7426-6
(Developments in Biologicals 108)

Chudy M, Stahl-Hennig C, Berger A, Nübling M, Hunsmann G, Rabenau HF, Löwer J (2002): Hepatitis A virus infection in tamarins: experimental transmission via contaminated factor VIII concentrates.
J Infect Dis 185: 1170-1173.
Online-Abstract

Cichutek K, Flory E, Seitz R, Heiden M (2002): Regulatorische Aspekte der Anwendung humaner Stammzellen.
Bundesgesundheitsbl – Gesundheitsforsch – Gesundheitsschutz 45: 108-112.
Online-Abstract Text

Cohen-Haguenauer O, Rosenthal F, Gänsbacher B, Bolhuis R, Dorsch-Häsler K, Eshhar Z, Gahrton G, Hokland, Melani C, Rankin E, Thielemans K, Vile R, Zwierzina H, Cichutek K (2002): Opinion paper on the current status of the regulation of gene therapy in Europe.
Hum Gene Ther 13: 2085-2110.

Cußler K, Borrmann W, Werner E (2002): Fortschritte beim Ersatz von Tierversuchen in der Qualitätskontrolle von Clostridien-Impfstoffen.
Tierärztliche Wochenschrift 109: 172-177.

Cußler, K, Halder M, Hendriksen C (2002): Future activities: ECVAM and the quality control of biologicals.
ATLA 30: 225-226.
Online-Abstract

Cussler K, Kulpa J, Calver J (2002): The International Symposium on Regulatory Testing and Animal Welfare: Recommendations on Best Scientific Practices for Biologicals: Safety and Potency Evaluations.
ILAR J 43: S126-S128.

Damert A, Miquerol L, Gertsenstein M, Risau W, Nagy A (2002): Insufficient VEGFA activity in yolk sac endoderm compromises haematopoietic and endothelial differentiation.
Development 129: 1881-1892.
Online-Abstract

Demirhan I, Kanyalkar M, Chandra A, Doerr HW, Coutinho E, Löwer J, Saran A, Chandra P (2002): Docking studies reveal a selective binding of D-penicillamine to the transactivator protein of human immunodeficiency virus type 1.
FEBS Lett 516: 43-46.
Online-Abstract

Ebert E, Hartinger J, Balks E, Cußler K (2002): Prevalidation of serological methods to replace animal challenge tests required for the potency testing of bacterial vaccines.
Final report for the ECVAM research project.

Etscheid M, Beer N, Fink, E, Seitz R, Dodt J (2002): Cleavage of HMW kininogen and kinin release by the plasma hyaluronan-binding serin protease. 46th Meeting GTH 2002, Erfurt.
Ann Hematol 81: A 16.

Etscheid M, Beer N, Fink E, Seitz S, Dodt J (2002): The hyaluronan-binding serine protease from human plasma cleaves HMW and LMW kininogen and releases bradykinin.
Biol Chem 383: 1633-1643.
Online-Abstract

Etscheid M, Beer N, Seitz R, Dodt J (2002): Regulation of the plasma hyaluronan-binding serine protease. 46th Meeting GTH 2002, Erfurt.
Ann Hematol 81: A 16.

Gelderblom H, Boller K: Human Immunodeficiency Virus: From Virus Structure to Pathogenesis.
Bogner E and Holzenburg A (Hrsg.), Structure-Function Relationships of Human Pathogenic Viruses New York and London: Kluwer Academic/Plenum Publishers, 2002. 295-330 ISBN 0-306-46768-2

Grob M, Reindl J, Vieths S, Wüthrich B, Ballmer-Weber BK (2002): Heterogeneity of banana allergy : characterization of allergens in banana-allergic patients.
Ann Allergy Asthma Immunol 89: 513-516.

Haase M (2002): Human recombinant factor IX : safety and efficacy studies in hemophilia B patients previously treated with plasma-derived factor IX concentrates.
Blood 100: 4242.
Online-Abstract

Halbauer J (2002): Die Anforderungen der Medizinprodukte-Sicherheitsplan-Verordnung für In-vitro-Diagnostika im Rahmen des Medizinproduktegesetzes - Praxisorientierte Hilfe für Hersteller, Bevollmächtigte und Anwender zur Meldung von Vorkommnissen.
Medizin-Produkte-Recht.

Halder M, Balls M, Hendriksen C, Cußler K (2002): ECVAM`s activities on biologicals.
ATLA 30: 125-128.
Online-Abstract

Halder M, Hendriksen C, Cußler K, Balls M (2002): ECVAM's Contributions to the Implementation of the Three Rs in the Production and Quality Control of Biologicals.
ATLA 30: 93-108.
Online-Abstract

Hartinger J, Hendriksen C, Morton D, Steen B, Cussler K (2002): Humane Endpoints Replace Lethal Parameters in Vaccine Quality Control.
NCA Newsletter: 1-5.

Hartmann K, Keller-Stanislawski B (2002): Rekombinante Hepatitis-B-Impfstoffe und Verdachtsfälle unerwünschter Reaktionen. Eine Bewertung der Spontanerfassungsdaten des Paul-Ehrlich-Instituts 1995 bis 2000.
Bundesgesundheitsbl - Gesundheitsforsch - Gesundheitsschutz 45: 355-363.
Online-Abstract Volltext

Heiden M, Seitz R (2002): Quality of therapeutic plasma – requirements for marketing authorization.
Thromb Res 107: S47-S51.
Online-Abstract

Hendriksen C, Cußler K, Halder M (2002): ECVAM`s role in the implementation of the Three Rs concept in the field of biologicals.
ATLA 30: 41-46.
Online-Abstract

Hendriksen C, Cußler K (2002): Meeting Report: Advancing Science and Elimination of the Use of Laboratory Animals for Developmenz and Control of Vaccines and Hormones.
NCA Newsletter: 8-10.

Hermann C, Spreitzer I, Schröder NW, Morath S, Lehner MD, Fischer W, Schutt C, Schumann RR, Hartung T (2002): Cytokine induction by purified lipoteichoic acids from various bacterial species-role of LBP, sCD14, CD14 and failure to induce IL-12 and subsequent IFN-gamma release.
Eur J Immunol 32: 541-551.
Online-Abstract

Hiller R, Laffer S, Harwanegg C, Huber M, Schmidt WM, Twardosz A, Barletta B, Becker WM, Blaser K, Breiteneder H, Chapman M, Crameri R, Duchêne M, Ferreira F, Fiebig H, Hoffmann-Sommergruber K, King TB, Kleber-Janke T, Kurup VP, Lehrer SB, Lidholm J, Müller U, Pini C, Reese G, Scheiner O, Scheynius A, Shen HD, Spitzauer S, Suck R, Swoboda I, Thomas W, Tinghino R, Van Hage-Hamsten M, Virtanen T, Kraft D, Müller MW, Valenta R (2002): Microarrayed allergen molecules: diagnostic gatekeepers for allergy treatment.
FASEB J 16: 414-416.

Hoff M, Krail M, Kästner M, Haustein D, Vieths S (2002): Fusarium culmorum causes strong degradation of pollen allergens in extract mixtures.
J Allergy Clin Immunol 109: 96-101.
Online-Abstract

Holzhauser T, Stephan O, Vieths S (2002): Detection of potentially allergenic hazelnut (Corylus avellana) residues in food: a comparative study with DNA PCR-ELISA and protein sandwich-ELISA.
J Agric Food Chem 50: 5808-5815.
Online-Abstract

Holznagel E, Norley S, Holzammer S, Coulibaly C, Kurth R (2002): Immunological changes in simian immunodeficiency virus (SIV(agm))- infected African green monkeys (AGM): expanded cytotoxic T lymphocyte, natural killer and B cell subsets in the natural host of SIV(agm).
J Gen Virol 83: 631-640.
Online-Abstract

Kaul S, Fötisch K, Karamloo F, Vieths S, Hoffmann A (2002): Replacement of murine sera by allergen-specific monoclonal IgE antibodies: a new approach for the characterisation of allergen extracts.
Dev Biol 111: 109-115.

Kegel B, Bonifas U, Silberbach K, Krämer B, Weißer K (2002): In vitro determination of specific toxicity in tetanus vaccines. In: Advancing Science and Elimination of the Use of Laboratory Animals for Development and Control of Vaccines and Hormones.
Dev Biol 111: 27-32.

Keller-Stanislawski B, Hartmann K (2002): Auswertung der Meldungen von Verdachtsfällen auf Impfkomplikationen nach dem Infektionsschutzgesetz.
Bundesgesundheitsbl-Gesundheitsforsch-Gesundheitsschutz 45: 344-354.
Online-Abstract Text

Klawonn W, Cußler K, Dräger KG, Gyra H, Köhler J, Zimmer K, Heß RG (2002): Zur Bedeutung von allergischem Hauttest mit Johnin, Antikörper-ELISA, kultureller Kotuntersuchung sowie der Impfung für die Sanierung dreier chronisch Paratuberkulose-infizierter Milchviehherden in Rheinland-Pfalz.
Dtsch Tierärztl Wochenschr 109: 510-516.

Kleine-Tebbe J, Fuchs T, Lepp U, Niggemann B, Saloga J, Vieluf I, Vieths S, Werfel T, Zuberbier T, Jäger L (2002): In-vitro-Diagnostik von Nahrungsmittel-Allergien: Positionspapier der Deutschen Gesellschaft für Allergologie und klinische Immunologie (DGAI) und des Ärzteverbandes deutscher Allergologen (ÄDA).
Allergologie 25: 341-349.

Kleine-Tebbe J, Wangorsch A, Vogel L, Crowell DN, Haustein UF, Vieths S (2002): Severe oral allergy syndrome and anaphylactic reactions caused by a Bet v 1-related PR-10 protein in soybean, SAM22.
J Allergy Clin Immunol 110: 797-804.
Online-Abstract

König RR, Flory E, Steidl S, Neumann J, Coulibaly C, Holznagel E, Holzammer S,, Norley S, Cichutek K (2002): Engineered CD4- and CXCR4-using simian immunodeficiency virus from African green monkeys is neutralization sensitive and replicates in nonstimulated lymphocytes.
J Virol 76: 10627-36.
Online-Abstract

Kreß J, Beer N, Seitz R, Dodt J, Etscheid M (2002): Interaction of the plasma hyaluronan-binding serine protease with extracellular matrix proteins. 46th Meeting GTH Erfurt 2002, accepted.
Ann Hematol 81: A 47.

Larsen Le Tarnec C, Hendriksen C, Bruckner L, Cußler K: Replacement, reduction and refinement of the use animals in the quality control of vaccines.
In: Proceedings of the International Symposium (2002), Strasbourg, 7-8 November. Strasbourg: Council of Europe, 2002

Lehrer SB, Ayuso R, Reese G (2002): Current understanding of food allergens.
Ann N Y Acad Sci 964: 69-85.

Lelie PN, van Drimmelen AAJ, Cuypers HTM, Best S, Dax EM, Stramer S, Hyland CAllain JP, Moncharmont P, Defer C, Nübling CM, Glauser A, da Silva Cardoso M, Viret JF, Lankinen M, Grillner L, Wirthmüller U, Coste J, Schottstedt V, Masecar B (2002): Sensitivity of HCV-RNA and HIV-RNA blood screening assays.
Transfusion 42: 527-536.
Online-Abstract

Lepp US, Ehlers I, Erdmann S, Fuchs T, Henzgen M, Kleine-Tebbe J, Niggemann B, Saloga J, Vieluf I, Vieths S, Zuberbier T, Werfel T (2002): Therapiemöglichkeiten bei der IgE-vermittelten Nahrungsmittelallergie.
Allergologie 25: 585-590.

Lüttkopf D, Müller U, Skov PS, Ballmer-Weber BK, Wüthrich B, Skamstrup Hansen K, Poulsen LK, Kästner M, Haustein D, Vieths S (2002): Comparison of four variants of a major allergen in hazelnut (Corylus avellana) Cor a 1.04 with the major hazel pollen allergen Cor a 1.01.
Mol Immunol 38: 515-525.
Online-Abstract

Luick K, Gottschaldt J, Schulze F, Werner E, Erler W, Borrmann E (2002): Anwendung des Toxin-Bindungs-Inhibitionstests zur Wirksamkeitsprüfung von Cloistridium-novyi-Tyb-B-Alphatoxoid-Impfstoffen.
Dtsch Tierärztl Wochenschr 109: 137-216.

Meyer C, Rasch G, Keller-Stanislawski B, Schnitzler N (2002): Anerkannte Impfschäden in der Bundesrepublik Deutschland 1990-1999.
Bundesgesundheitsbl-Gesundheitsforsch-Gesundheitsschutz 45: 364-370.
Online-Abstract Text

Montag-Lessing T, Däubener W, Dörner R, Greis O, Hornei B, Strobel J, Walther-Wenke G (2002): Einführung des „Predonation Sampling“.
Bundesgesundheitsblatt – Gesundheitsforschung – Gesundheitsschutz 45: 756.

Morath S, Geyer A, Spreitzer I, Hermann C, Hartung T (2002): Structural decomposition and heterogeneity of commercial lipoteichoic Acid preparations.
Infect Immun 70: 938-44.
Online-Abstract

Münk C, Brandt SM, Lucero G, Landau NR (2002): A dominant block to HIV replication at reverse transcription in simian cells.
Proc Natl Acad Sci 99: 13843-13848. Epub Oct. 4.
Online-Abstract

Neugebauer BM, Goy C, Budek I, Seitz R (2002): Comparison of two von Willebrand factor collagen-binding assays with different binding affinities for low, medium and high multimers of von Willebrand factor.
Semin Thromb Hemost 28: 139-148.
Online-Abstract

Neugebauer BM, Goy C, Seitz R (2002): A collagen binding assay: an additional method for von Willebrand factor activity in therapeutic concentrates.
Thromb Haemost 88: 871-872.

Neugebauer BM, Volkers P, Seitz R (2002): von Willebrand Factor Potency Determination by Collagen Binding Assay A Collaborative Study for the Establishment of a European Pharmacopoeia Method.
Pharmeuropa 14.2: 315-327.

Niebert M, Rogel-Gaillard C, Chardon P, Tönjes RR (2002): Characterization of chromosomally assigned replication-competent gamma porcine endogenous retroviruses derived from a large white pig and expression in human cells.
J Virol 76: 2714-2720.
Online-Abstract

Niebert M, Scheef G, Tönjes RR (2002): Wieviele funktionale porcine endogene Retroviren (PERV) hat das Schwein?.
Transplantationsmedizin 14: 166-170.
Online-Abstract

Nübling CM, Unger G, Chudy M, Raia S, Löwer J (2002): Sensitivity of HCV core antigen and HVC RNA detection in the early infection phase.
Transfusion 42: 1037-1045.

Pani MA, Wood JP, Bieda K, Tönjes RR, Usadel KH, Badenhoop K (2002): The variable endogenous retroviral insertion in the human complement C4 gene: a transmission study in type I diabetes mellitus.
Hum Immunol 63: 481-484.
Online-Abstract

Pastorello EA, Vieths S, Pravettoni V, Farioli L, Trambaioli C, Fortunato D, Lüttkopf D, Calamari M, Ansaloni R, Scibilia J, Ballmer-Weber B, Poulsen LK, Wüthrich B, Skamstrup Hansen K, Robino AM, Ortolani C, Conti A (2002): Identification of hazelnut allergens in sensitive patients with positive double-blind placebo-controlled food challenge results.
J Allergy Clin Immunol 109: 563-570.
Online-Abstract

Pfleiderer M, Löwer J, Kurth R (2002): Cold-attenuated live influenza vaccines, a risk-benefit assessment.
Vaccine 20: 886-894.
Online-Abstract

Plesker R, Coulibaly C, Hetzel U (2002): A spontaneous uterine sarcoma in a rhesus monkey (Macaca mulatta).
Journal of Veterinary Medicine, Series A : Physiology Pathology Clinical Medicine / Zentralblatt für Veterinärmedizin 49: 428-429.
Online-Abstract

Prinz M, Montrasio F, Klein MA, Schwarz P, Priller J, Odermatt B, Pfeffer K, Aguzzi A (2002): Lymph nodal prion replication and neuroinvasion in mice devoid of follicular dendritic cells.
Proc Natl Acad Sci USA 99: 919-924.
Online-Abstract

Reindl J, Rihs HP, Scheurer S, Wangorsch A, Haustein D, Vieths S (2002): IgE reactivity to profilin in pollen-sensitized subjects with adverse reactions to banana and pineapple.
Int Arch Allergy Immunol 128: 105-114.
Online-Abstract

Rosskopf-Streicher U, Johannes S, Cussler K (2002): Potency Testing of Inactivated Erysipelas Vaccines by ELISA - Influence of the Adjuvant on Antibody development.
Development in Biological Strandardization 111: 159-162.

Rosskopf-Streicher U, Johannes S, Gyra H, Beckmann R, Cussler K (2002): Batch Potency Testing of Inactivated Erysipelas Vaccines by ELISA - Development, Validation and Implementation.
Development in Biological Standardization 111: 153-158.

Scheef G, Fischer N, Flory E, Schmitt I, Tönjes RR (2002): Transcriptional regulation of porcine endogenous retroviruses released from porcine and infected human cells by heterotrimeric protein complex NF-Y and impact of immunosuppressive drugs.
J Virol 76: 12553-12563.
Online-Abstract

Scheef G, Fischer N, Tönjes RR (2002): Porcine endogene Retroviren (PERV): Die Passagierung von Viren in humanen Zellen führt zur Adaptation der transkriptionellen Aktivität durch Enhancer-Multimerisierung.
Transplantationsmedizin 14: 246-253.
Online-Abstract

Scheller C, Sopper S, Chen P, Flory E, Koutsilieri E, Racek T, Ludwig S, Meulen V, Jassoy C (2002): Caspase inhibition activates HIV in latently infected cells. Role of tumor necrosis factor receptor 1 and CD95.
J Biol Chem 277: 15459-64. Epub Feb. 19.
Online-Abstract

Scheller C, Sopper S, Ehrhardt C, Flory E, Chen P, Koutsilieri E, Ludwig S, Meulen V, Jassoy C (2002): Caspase inhibitors induce a switch from apoptotic to proinflammatory signaling in CD95-stimulated T lymphocytes.
Eur J Immunol 32: 2471-2480.
Online-Abstract

Scheu S, Alferink J, Pötzel T, Barchet W, Kalinke U, Pfeffer K (2002): Targeted disruption of LIGHT causes defects in costimulatory T cell activation and reveals cooperation with lymphotoxin ß in mesenteric lymph node genesis.
J Exp Med 195: 1613-1624.
Online-Abstract

Schwanig M (2002): Die Zulassung von Impfstoffen - Regelungen und Prozesse auf europäischer Ebene.
Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz 45: 338-343.
Online-Abstract Volltext

Seitz H, Blümel J, Schmidt I, Willkommen H, Löwer J (2002): Comparable virus inactivation by bovine or vegetable derived Tween 80 during solvent/detergent treatment.
Biologicals 30: 197-205.
Online-Abstract

Seitz R, Burger R, Gerlich W, Gürtler L, Heiden M, Hitzler W, Jansen B, Klamm H, Lefèvre H, Löwer J, Ludwig WD, Montag-Lessing T, Paessens A, Pauli G, Schlenkrich U, Werner E, Willkommen H, Hagedorn HJ (2002): Treponema pallidum.
Bundesgesundheitsblatt – Gesundheitsforschung – Gesundheitsschutz 45: 818-826.
Online-Abstract

Seitz R: Overall Blood Supply Strategy with Regard to vCJD.
In: Scharrer I, Schramm W (Hrsg.), 32. Hämophilie-Symposium, Hamburg, 2001. Berlin, Heidelberg: Springer, 2002. 19-24.

Siso S, Puig B, Varea R, Vidal E, Acin C, Prinz M, Montrasio F, Badiola J, Aguzzi A, Pumarola M, Ferrer I (2002): Abnormal synaptic protein expression and cell death in murine scrapie.
Acta Neuropathol 103: 615-626.
Online-Abstract

Specke V, Plesker R, Coulibaly C, Boller K, Denner J (2002): Productive infection of a mink cell line with porcine endogenous retroviruses (PERVs) but lack of transmission to minks in vivo.
Arch Virol 147: 305-319.
Online-Abstract

Specke V, Schuurman HJ, Plesker R, Coulibaly C, Özel M, Langford G, Kurth R, Denner J (2002): Virus safety in xenotransplantation : first exploratory in vivo studies in small laboratory animals and non-human primates.
Transpl Immunol 9: 281-288.
Online-Abstract

Spreitzer I, Fischer M, Hartzsch K, Lüderitz-Püchel U, Montag T (2002): Comparative study of rabbit pyrogen test and human whole blood assay on human serum albumin.
ALTEX 19 Suppl. 1: 73-75.
Online-Abstract

Steidl S, Stitz J, Schmitt I, König R, Flory E, Schweizer M, Cichutek K (2002): Coreceptor Switch of [MLV(SIVagm)] Pseudotype Vectors by V3-Loop exchange.
Virology Sep. 1; 300: 205-216.
Online-Abstract

Stephan O, Möller N, Lehmann S, Holzhauser T, Vieths (2002): Development and validation of two dipstick type immunoassays for determination of trace amounts of peanut and hazelnut in processed foods.
Eur Food Res Technol 215: 431-436.
Online-Abstract

Thorpe SJ, Sands D, Rautmann G, Schäffner G (2002): International collaborative study to evaluate methods for quantification of anti-D in immunoglobin preparations.
Vox Sang 83: 42-50.
Online-Abstract

Vieths S, Lüttkopf D, Reindl J, Anliker MD, Wüthrich B, Ballmer-Weber BK (2002): Allergens in celery and zucchini.
Allergy 57: 100-105.
Online-Abstract

Vieths S, Scheurer S, Ballmer-Weber BK (2002): Current understanding of cross-reactivity of food allergens and pollen.
Ann N Y Acad Sci 964: 47-68.
Online-Abstract

Vincent S, Tigaud I, Schneider H, Buchholz CJ, Yanagi Y, Gerlier D (2002): Restriction of measles virus RNA synthesis by a mouse host cell line: trans-complementation by polymerase components or a human cellular factor(s).
J Virol 76: 6121-6130.
Online-Abstract

Volkers P: Conclusions workshop V: Statistical aspects of validation studies.
In: European Department for the Quality of Medicine council of Europe, Strasbourg (Hrsg.), Replacement, reduction and refinement of the use of animals in the quality control of vaccines: International symposium ; Strasbourg, 7-8 Nov. 2002 ; scientific programme. Strasbourg, 2002. 73-75.

Willkommen H, Blümel J, Stühler A, Löwer J (2002): Detection of parvovirus B19 DNA in solvent-detergent plasma.
Vox Sang 83: 167-168.
Online-Abstract

Zent O, Arras-Reiter C, Broeker M, Hennig R (2002): Immediate allergic reactions after vaccinations – a post-marketing surveillance review.
Eur J Pediatr 161: 21-25.
Online-Abstract

Zuberbier T, Pfrommer C, Specht K, Vieths S, Bastl-Borrmann R, Worm M, Henz BM (2002): Aromatic components of food as novel eliciting factors of pseudoallergic reactions in chronic urticaria.
J Allergy Clin Immunol 109: 343-348.
Online-Abstract

This Page